Beranda › Leukemia › Alabama › Birmingham
Uji klinis Leukemia di Birmingham, AL
10 studi untuk Leukemia mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
- Quetzal Site 16, Birmingham
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Menerima pesertaFase 2
- University of Alabama - Birmingham, Birmingham
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Menerima pesertaFase 2
- The University of Alabama at Birmingham, Birmingham
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Menerima pesertaFase 1/2
- Dren Investigational Site, Birmingham
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Menerima pesertaStudi observasional
- Children's Hospital of Alabama, Birmingham
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
Menerima pesertaFase 1
- University of Alabama at Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Birmingham
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
Menerima pesertaFase 2
- University of Alabama at Birmingham, Birmingham
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
Menerima pesertaFase 2
- University of Alabama at Birmingham, Birmingham
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Menerima pesertaFase 1
- University of Alabama at Birmingham, Birmingham
Uji klinis Leukemia di kota lain
- Houston, TX28 studi
- Boston, MA25 studi
- New York City, NY19 studi
- Los Angeles, CA16 studi
- Chicago, IL16 studi
- Durham, NC13 studi
- Baldwin Park, CA12 studi
- Columbus, OH12 studi
- Nashville, TN12 studi
- Philadelphia, PA12 studi
- Milwaukee, WI11 studi
- Atlanta, GA11 studi
Studi lain di Birmingham
- Kanker (semua jenis)30 studi
- Kanker Payudara24 studi
- Obesitas23 studi
- Kanker Ovarium23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Leukemia Mieloid Akut21 studi
- Mieloma Multipel18 studi
- PPOK17 studi
- Penyakit Kardiovaskular17 studi
- Kelebihan Berat Badan16 studi
- Kanker Endometrium16 studi
- Diabetes Tipe 216 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.